title: Secondary prophylaxis in an adult patient with severe haemophilia A. Factor VIII consumption and effectiveness.
abstract: Primary prophylaxis has been proven as the gold standard for preserving joint function in severe haemophilia. Secondary prophylaxis in children has also been shown to have a more beneficial effect on joint protection as on-demand treatment. The outcome of delayed secondary prophylaxis started in adulthood is rarely studied. The case of a man (age: 47 years) with severe haemophilia A demonstrates the successful switch from on-demand therapy to prophylaxis with subsequent reduction of annual bleeding rate and number of days of work lost. The small increase of factor VIII consumption (16%) and the decrease of bleeding rate are compared with data from two recently published prospective studies.
  
  
  CONCLUSIONS
  An optimal dosing schedule needs to be discussed and larger and longer prospective studies targeting the benefits of secondary prophylaxis with factor VIII started in adulthood are necessary.
authors: German Haemophilia Society, Germany. sschlenkrich@web.de
authors: S
authors: S
authors: Schlenkrich
authors: C
authors: C
authors: Schubert
mesh_terms: D003029:Coagulants / Q000008:administration & dosage; D005169:Factor VIII / Q000008:administration & dosage*; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy*; D006470:Hemorrhage / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007276:Injections, Intraventricular; D007592:Joint Diseases / Q000209:etiology / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D055502:Secondary Prevention / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D003029:Coagulants; D005169:Factor VIII